Clinical Trials Directory

Trials / Completed

CompletedNCT03102879

Encapsulated Mesenchymal Stem Cells for Dental Pulp Regeneration.

Encapsulated Mesenchymal Stem Cells for Endodontic Treatment of Permanent Teeth With Apical Lesion: a Controlled Clinical Trial.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
36 (actual)
Sponsor
Universidad de los Andes, Chile · Academic / Other
Sex
All
Age
16 Years – 58 Years
Healthy volunteers
Not accepted

Summary

To compare the dental survival in a period of one year of mature permanent teeth with apical lesion following the administration of encapsulated Mesenchymal Stem Cells under a regenerative endodontic procedure and a conventional root canal treatment.

Detailed description

This is a controlled clinical trial designed to evaluate the survival of mature permanent teeth with apical lesion treated with regenerative endodontic procedure (REP) based on encapsulated Mesenchymal Stem Cells in a biological scaffold. The REP will be compared to the conventional endodontic therapy. The REP is based on the use of umbilical cord-derived mesenchymal stem cells encapsulated in a plasma-derived biomaterial . The study group will use the disinfection protocol, indicated in the clinical considerations for regenerative procedures as recommended by the American Association of Endodontics, using a paste of calcium hydroxide prepared with double-distilled water as intracanal medication, and will be operated with REP using allogeneic stem cells in a scaffold, while the control group will be operated with conventional endodontic therapy alone. This clinical trial pretends to determine the dental survival of the tooth with mature apex and apical lesion, over a period of one year.

Conditions

Interventions

TypeNameDescription
PROCEDURERegenerative Endodontic ProcedureCoronary access, conductometry, mechanized instrumentation, irrigation with sodium hypochlorite, intracanal calcium hydroxide medication and obturation with stem cells.
PROCEDUREConventional Root Canal TreatmentCoronary access, conductometry, mechanized instrumentation, irrigation with sodium hypochlorite, intracanal calcium hydroxide medication and obturation with gutta-percha.

Timeline

Start date
2016-09-23
Primary completion
2018-09-30
Completion
2018-09-30
First posted
2017-04-06
Last updated
2020-01-21
Results posted
2020-01-21

Locations

1 site across 1 country: Chile

Source: ClinicalTrials.gov record NCT03102879. Inclusion in this directory is not an endorsement.